Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Vaccine
Pharma
Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial
Vaxxas has secured funding to support clinical development of its needle-free COVID-19 vaccine, stuffing its coffers with $23 million from investors.
Nick Paul Taylor
Dec 6, 2022 10:25am
FDA approves single-vial version of GSK's Menveo vaccine
Oct 18, 2022 10:00am
MIT timed drug release tech opens door to self-boosting vaccines
Jul 18, 2022 8:20am
Valneva wins nod in U.K. for its COVID-19 vaccine
Apr 14, 2022 11:35am
Novavax finally submits its COVID-19 vaccine to the FDA
Jan 31, 2022 3:55pm
Square pumping $74M into Kenya manufacturing facility
Dec 9, 2021 9:40am
